Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimalarial activity: a QSAR modeling using CODESSA PRO software.

Alan R Katritzky1, Oleksandr V Kulshyn, Iva Stoyanova-Slavova

  • 1Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, FL 32611, USA. katritzky@chem.ufl.edu

Bioorganic & Medicinal Chemistry
|January 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of ALKBH5 demethylase of m<sup>6</sup>A pathway potentiates HIV-1 reactivation from latency.

Virology journal·2025
Same author

Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus Inhibitors.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

USP14 is crucial for proteostasis regulation and α-synuclein degradation in human SH-SY5Y dopaminergic cells.

Heliyon·2025
Same author

Computational Methods for Modeling Lipid-Mediated Active Pharmaceutical Ingredient Delivery.

Molecular pharmaceutics·2025
Same author

RNA m<sup>6</sup>A methyltransferase activator affects anxiety-related behaviours, monoamines and striatal gene expression in the rat.

Acta neuropsychiatrica·2024
Same author

Integration of virtual and physical screening.

Drug discovery today. Technologies·2024
Same journal

Transport specificity of FpvA and FpvB for pyoverdine-antibiotic conjugates in Pseudomonas aeruginosa.

Bioorganic & medicinal chemistry·2026
Same journal

Design and engineering of μO-conotoxin MfVIA mutants to enhance Na<sub>V</sub>1.8 inhibition and analgesic efficacy in inflammatory pain.

Bioorganic & medicinal chemistry·2026
Same journal

Recent advances in Camptothecin-derived antibody-drug conjugates.

Bioorganic & medicinal chemistry·2026
Same journal

CDK4/6-targeted therapy: From clinical inhibitors to emerging strategies to overcome resistance.

Bioorganic & medicinal chemistry·2026
Same journal

Coumarin-sulfonamide hybrids as PKM2 activators induce metabolic reprogramming and suppress ovarian cancer cell growth.

Bioorganic & medicinal chemistry·2026
Same journal

Recent advances in the development of small-molecule drugs based on covalent reversible inhibitors.

Bioorganic & medicinal chemistry·2026
See all related articles

Quantitative structure-activity relationship (QSAR) models predict antimalarial activity against Plasmodium falciparum strains D6 and NF54. Molecular descriptors reveal insights into the compounds

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Parasitology

Background:

  • Malaria remains a significant global health challenge, necessitating the development of novel antimalarial drugs.
  • Understanding the relationship between chemical structure and biological activity is crucial for drug discovery.
  • Plasmodium falciparum is the deadliest malaria parasite, with drug resistance being a major concern.

Purpose of the Study:

  • To develop quantitative structure-activity relationship (QSAR) models for predicting the antimalarial activity of diverse compound sets.
  • To investigate two strains of Plasmodium falciparum: D6 and NF54.
  • To identify key molecular descriptors correlated with antimalarial efficacy.

Main Methods:

  • Calculation of molecular descriptors (geometrical, topological, quantum mechanical, electronic) using CODESSA PRO software.

Related Experiment Videos

  • Development of multilinear regression models for QSAR analysis.
  • Internal validation of the developed QSAR models.

    • Main Results:

    • Satisfactory QSAR models were achieved for both D6 (R2 = 0.84) and NF54 (R2 = 0.89) Plasmodium falciparum strains.
    • The models demonstrated good internal validation, indicating reliability.
    • Identified molecular descriptors were linked to the antimalarial protection mechanism.

    Conclusions:

    • QSAR modeling is an effective approach for predicting antimalarial activity.
    • The identified molecular descriptors provide insights into the mechanism of action against Plasmodium falciparum.
    • These findings can guide the design of new, more potent antimalarial compounds.